5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Health-related quality of life (HRQoL) at final analysis of the GALAHAD study of niraparib in patients with metastatic castration-resistant prostate cancer (mCRPC) and DNA repair defects (DRD)
    Meeting Abstract

    Smith, M. R.; Sandhu, S. K.; George, D. J.; Chi, K. N.; Saad, F.; Thiery-Vuillemin, A.; Stahl, O.; Olmos, D.; Danila, D.; Gafanov, R.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Prospective evaluation of clinical outcomes using a multiplex liquid biopsy targeting diverse resistance mechanisms in metastatic prostate cancer
    Journal Article

    Sperger, J. M.; Emamekhoo, H.; McKay, R. R.; Stahlfeld, C. N.; Singh, A.; Chen, X. E.; Kwak, L.; Gilsdorf, C. S.; Wolfe, S. K.; Wei, X. X.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Therapeutic implications of germline testing in patients with advanced cancers
    Journal Article

    Stadler, Z. K.; Maio, A.; Chakravarty, D.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E.; Tkachuk, K.; Fong, C. J.; Nguyen, B.; Erakky, A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Randomized phase III trial of gemcitabine and cisplatin with bevacizumab or placebo in patients with advanced urothelial carcinoma: Results of CALGB 90601 (Alliance)
    Journal Article

    Rosenberg, J. E.; Ballman, K. A.; Halabi, S.; Atherton, P. J.; Mortazavi, A.; Sweeney, C.; Stadler, W. M.; Teply, B. A.; Picus, J.; Tagawa, S. T.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A qualitative framework of non-selection factors for cytoreductive nephrectomy
    Journal Article

    Silagy, A. W.; Attalla, K.; Dinatale, R. G.; Weiss, K. L.; Weng, S.; Mano, R.; Iosepovici, S.; Marcon, J.; Reznik, E.; Kotecha, R. R.; more...
    World Journal of Urology (2021)

    Fulltext@MSK | Save
  • Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors
    Journal Article

    Ashkar, R.; Feldman, D. R.; Adra, N.; Zaid, M. A.; Funt, S. A.; Althouse, S. K.; Perkins, S. M.; Snow, C. I.; Lazzara, K. M.; Sego, L. M.; more...
    Investigational New Drugs (2021)

    Fulltext@MSK | Save
  • A phase II, nonrandomized open trial assessing pain efficacy with radium-223 in symptomatic metastatic castration-resistant prostate cancer
    Journal Article

    McHugh, D.; Tagawa, S.; Moryl, N.; Milowsky, M.; Heller, G.; Osborne, J.; Rathkopf, D.; Basch, E.; Pandit-Taskar, N.; Morris, M. J.
    Clinical Genitourinary Cancer (2021)

    Fulltext@MSK | Save
  • A phase I/II study to assess the safety and efficacy of pazopanib and pembrolizumab combination therapy in patients with advanced renal cell carcinoma
    Journal Article

    Chowdhury, S.; Infante, J. R.; Hawkins, R.; Voss, M. H.; Perini, R.; Arkenau, T.; Voskoboynik, M.; Aimone, P.; Naeije, I.; Reising, A.; more...
    Clinical Genitourinary Cancer (2021)

    Fulltext@MSK | Save
  • Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement
    Guidelines

    Bratslavsky, G.; Mendhiratta, N.; Daneshvar, M.; Brugarolas, J.; Ball, M. W.; Metwalli, A.; Nathanson, K. L.; Pierorazio, P. M.; Boris, R. S.; Singer, E. A.; more...
    Cancer (2021)

    Fulltext@MSK | Save
  • Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma
    Journal Article

    Silagy, A. W.; Kotecha, R. R.; Weng, S.; Holmes, A.; Singla, N.; Mano, R.; Attalla, K.; Weiss, K. L.; DiNatale, R. G.; Patil, S.; more...
    Cancer (2021)

    Fulltext@MSK | Save